Difference between revisions of "Template:Glutamate receptor modulators"

From blackwiki
Jump to navigation Jump to search
imported>Ronhjones
m (subst:'ing, replaced: {{•}} →  • (236) using AWB)
imported>Anypodetos
m (Simplify markup, replaced:  • →  • (236), <br> → <br /> using AWB)
Line 10: Line 10:
  
 
     | group1 = [[AMPA receptor|AMPA]]
 
     | group1 = [[AMPA receptor|AMPA]]
     | list1  = '''[[Ampakine|Agonists]]:''' [[5-Fluorowillardiine]]&#160;&#8226;  [[AMPA]]&#160;&#8226;  [[Domoic acid]]&#160;&#8226;  [[Quisqualic acid]]; ''[[Positive allosteric modulator]]s:'' [[Aniracetam]]&#160;&#8226;  [[Cyclothiazide]]&#160;&#8226;  [[CX-516]]&#160;&#8226;  [[CX-546]]&#160;&#8226;  [[CX-614]]&#160;&#8226;  [[CX-691]]&#160;&#8226;  [[CX-717]]&#160;&#8226;  [[Diazoxide]]&#160;&#8226;  [[Hydrochlorothiazide|HCTZ]]&#160;&#8226;  [[IDRA-21]]&#160;&#8226;  [[LY-392,098]]&#160;&#8226;  [[LY-404,187]]&#160;&#8226;  [[LY-451,395]]&#160;&#8226;  [[LY-451,646]]&#160;&#8226;  [[LY-503,430]]&#160;&#8226;  [[Oxiracetam]]&#160;&#8226;  [[PEPA (drug)|PEPA]]&#160;&#8226;  [[Piracetam]]&#160;&#8226;  [[Pramiracetam]]&#160;&#8226;  [[S-18986]]&#160;&#8226;  [[Sunifiram]]&#160;&#8226;  [[Unifiram]]<br/>'''Antagonists:''' [[ATPO]]&#160;&#8226;  [[Barbiturates]]&#160;&#8226;  [[Caroverine]]&#160;&#8226;  [[CNQX]]&#160;&#8226;  [[DNQX]]&#160;&#8226;  [[GYKI-52466]]&#160;&#8226;  [[NBQX]]&#160;&#8226;  [[Perampanel]]&#160;&#8226;  [[Talampanel]]&#160;&#8226;  [[Tezampanel]]&#160;&#8226;  [[Topiramate]]; ''[[Negative allosteric modulator]]s:'' [[GYKI-53,655]]
+
     | list1  = '''[[Ampakine|Agonists]]:''' [[5-Fluorowillardiine]]&nbsp; [[AMPA]]&nbsp; [[Domoic acid]]&nbsp; [[Quisqualic acid]]; ''[[Positive allosteric modulator]]s:'' [[Aniracetam]]&nbsp; [[Cyclothiazide]]&nbsp; [[CX-516]]&nbsp; [[CX-546]]&nbsp; [[CX-614]]&nbsp; [[CX-691]]&nbsp; [[CX-717]]&nbsp; [[Diazoxide]]&nbsp; [[Hydrochlorothiazide|HCTZ]]&nbsp; [[IDRA-21]]&nbsp; [[LY-392,098]]&nbsp; [[LY-404,187]]&nbsp; [[LY-451,395]]&nbsp; [[LY-451,646]]&nbsp; [[LY-503,430]]&nbsp; [[Oxiracetam]]&nbsp; [[PEPA (drug)|PEPA]]&nbsp; [[Piracetam]]&nbsp; [[Pramiracetam]]&nbsp; [[S-18986]]&nbsp; [[Sunifiram]]&nbsp; [[Unifiram]]<br/>'''Antagonists:''' [[ATPO]]&nbsp; [[Barbiturates]]&nbsp; [[Caroverine]]&nbsp; [[CNQX]]&nbsp; [[DNQX]]&nbsp; [[GYKI-52466]]&nbsp; [[NBQX]]&nbsp; [[Perampanel]]&nbsp; [[Talampanel]]&nbsp; [[Tezampanel]]&nbsp; [[Topiramate]]; ''[[Negative allosteric modulator]]s:'' [[GYKI-53,655]]
  
 
     | group2 = [[NMDA receptor|NMDA]]
 
     | group2 = [[NMDA receptor|NMDA]]
     | list2  = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]&#160;&#8226;  [[Glutamate]]&#160;&#8226;  [[Homoquinolinic acid]]&#160;&#8226;  [[Ibotenic acid]]&#160;&#8226;  [[NMDA]]&#160;&#8226;  [[Quinolinic acid]]&#160;&#8226;  [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]]&#160;&#8226;  [[ACPC]]&#160;&#8226;  [[ACPD]]&#160;&#8226;  [[Alanine]]&#160;&#8226;  [[Carboxycyclopropylglycine|CCG]]&#160;&#8226;  [[Cycloserine]]&#160;&#8226;  [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]]&#160;&#8226;  [[Fluoroalanine]]&#160;&#8226;  [[Glycine]]&#160;&#8226;  [[HA-966]]&#160;&#8226;  [[L-687,414]]&#160;&#8226;  [[Milacemide]]&#160;&#8226;  [[Sarcosine]]&#160;&#8226;  [[Serine]]&#160;&#8226;  [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]]&#160;&#8226;  [[Spermidine]]&#160;&#8226;  [[Spermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]&#160;&#8226;  [[AP-7 (drug)|AP7]]&#160;&#8226;  [[CGP-37849]]&#160;&#8226;  [[CGP-39551]]&#160;&#8226;  [[CGP-39653]]&#160;&#8226;  [[CGP-40116]]&#160;&#8226;  [[CGS-19755]]&#160;&#8226;  [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]]&#160;&#8226;  [[LY-233,053]]&#160;&#8226;  [[LY-235,959]]&#160;&#8226;  [[LY-274,614]]&#160;&#8226;  [[MDL-100,453]]&#160;&#8226;  [[Midafotel|Midafotel (d-CPPene)]]&#160;&#8226;  [[NPC-12,626]]&#160;&#8226;  [[NPC-17,742]]&#160;&#8226;  [[PBPD]]&#160;&#8226;  [[PEAQX]]&#160;&#8226;  [[Perzinfotel]]&#160;&#8226;  [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]&#160;&#8226;  [[SDZ-220581]]&#160;&#8226;  [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]]&#160;&#8226;  [[Caroverine]]&#160;&#8226;  [[Dexanabinol]]&#160;&#8226;  [[FPL-12495]]&#160;&#8226;  [[FR-115,427]]&#160;&#8226;  [[Hodgkinsine]]&#160;&#8226;  [[Magnesium]]&#160;&#8226;  [[MDL-27,266]]&#160;&#8226;  [[NPS-1506]]&#160;&#8226;  [[Psychotridine]]&#160;&#8226;  [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]&#160;&#8226;  [[3-MeO-PCP]]&#160;&#8226;  [[8a-Phenyldecahydroquinoline|8A-PDHQ]]&#160;&#8226;  [[Amantadine]]&#160;&#8226;  [[Aptiganel]]&#160;&#8226;  [[ARL-12,495]]&#160;&#8226;  [[ARL-15,896-AR]]&#160;&#8226;  [[ARL-16,247]]&#160;&#8226;  [[Budipine]]&#160;&#8226;  [[Delucemine]]&#160;&#8226;  [[Dexoxadrol]]&#160;&#8226;  [[Dextrallorphan]]&#160;&#8226;  [[Dieticyclidine]]&#160;&#8226;  [[Dizocilpine]]&#160;&#8226;  [[Endopsychosin]]&#160;&#8226;  [[Esketamine]]&#160;&#8226;  [[Etoxadrol]]&#160;&#8226;  [[Eticyclidine]]&#160;&#8226;  [[Gacyclidine]]&#160;&#8226;  [[Ibogaine]]&#160;&#8226;  [[Indantadol]]&#160;&#8226;  [[Ketamine]]&#160;&#8226;  [[Ketobemidone]]&#160;&#8226;  [[Loperamide]]&#160;&#8226;  [[Memantine]]&#160;&#8226;  [[Meperidine|Meperidine (Pethidine)]]&#160;&#8226;  [[Methadone]]&#160;&#8226;  [[Methorphan]] ([[Dextromethorphan]], [[Levomethorphan]])&#160;&#8226;  [[Methoxetamine]]&#160;&#8226;  [[Milnacipran]]&#160;&#8226;  [[Morphanol]] ([[Dextrorphan]], [[Levorphanol]])&#160;&#8226;  [[NEFA (drug)|NEFA]]&#160;&#8226;  [[Neramexane]]&#160;&#8226;  [[Nitrous oxide]]&#160;&#8226;  [[Noribogaine]]&#160;&#8226;  [[Orphenadrine]]&#160;&#8226;  [[PCPr]]&#160;&#8226;  [[Phencyclamine]]&#160;&#8226;  [[Phencyclidine]]&#160;&#8226;  [[Propoxyphene]]&#160;&#8226;  [[Remacemide]]&#160;&#8226;  [[Rhynchophylline]]&#160;&#8226;  [[Riluzole]]&#160;&#8226;  [[Rimantadine]]&#160;&#8226;  [[Rolicyclidine]]&#160;&#8226;  [[Sabeluzole]]&#160;&#8226;  [[Tenocyclidine]]&#160;&#8226;  [[Tiletamine]]&#160;&#8226;  [[Tramadol]]&#160;&#8226;  [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]]&#160;&#8226;  [[ACEA-1328]]&#160;&#8226;  [[1-Aminocyclopropanecarboxylic acid|ACPC]]&#160;&#8226;  [[Carisoprodol]]&#160;&#8226;  [[CGP-39653]]&#160;&#8226;  [[7-Chlorokynurenate|CKA]]&#160;&#8226;  [[DCKA]]&#160;&#8226;  [[Felbamate]]&#160;&#8226;  [[Gavestinel]]&#160;&#8226;  [[GV-196,771]]&#160;&#8226;  [[Kynurenic acid]]&#160;&#8226;  [[L-689,560]]&#160;&#8226;  [[L-701,324]]&#160;&#8226;  [[Lacosamide]]&#160;&#8226;  [[Licostinel]]&#160;&#8226;  [[LU-73,068]]&#160;&#8226;  [[MDL-105,519]]&#160;&#8226;  [[Meprobamate]]&#160;&#8226;  [[MRZ 2/576]]&#160;&#8226;  [[PNQX]]&#160;&#8226;  [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]]&#160;&#8226;  [[CO-101,244|CO-101,244 (PD-174,494)]]&#160;&#8226;  [[CP-101,606]]&#160;&#8226;  [[Eliprodil]]&#160;&#8226;  [[Haloperidol]]&#160;&#8226;  [[Ifenprodil]]&#160;&#8226;  [[Isoxsuprine]]&#160;&#8226;  [[Nylidrin]]&#160;&#8226;  [[Ro8-4304]]&#160;&#8226;  [[Ro25-6981]]&#160;&#8226;  [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]&#160;&#8226;  [[Co 101676]]&#160;&#8226;  [[1,3-Diaminopropane|Diaminopropane]]&#160;&#8226;  [[Diethylenetriamine]]&#160;&#8226;  [[Huperzine A]]&#160;&#8226;  [[Putrescine]]&#160;&#8226;  [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]]&#160;&#8226;  [[Diethyl ether]]&#160;&#8226;  [[Enflurane]]&#160;&#8226;  [[Ethanol|Ethanol (Alcohol)]]&#160;&#8226;  [[Halothane]]&#160;&#8226;  [[Isoflurane]]&#160;&#8226;  [[Methoxyflurane]]&#160;&#8226;  [[Toluene]]&#160;&#8226;  [[1,1,1-Trichloroethane|Trichloroethane]]&#160;&#8226;  [[2,2,2-Trichloroethanol|Trichloroethanol]]&#160;&#8226;  [[Trichloroethylene]]&#160;&#8226;  [[Xylene]]
+
     | list2  = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]&nbsp; [[Glutamate]]&nbsp; [[Homoquinolinic acid]]&nbsp; [[Ibotenic acid]]&nbsp; [[NMDA]]&nbsp; [[Quinolinic acid]]&nbsp; [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]]&nbsp; [[ACPC]]&nbsp; [[ACPD]]&nbsp; [[Alanine]]&nbsp; [[Carboxycyclopropylglycine|CCG]]&nbsp; [[Cycloserine]]&nbsp; [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]]&nbsp; [[Fluoroalanine]]&nbsp; [[Glycine]]&nbsp; [[HA-966]]&nbsp; [[L-687,414]]&nbsp; [[Milacemide]]&nbsp; [[Sarcosine]]&nbsp; [[Serine]]&nbsp; [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]]&nbsp; [[Spermidine]]&nbsp; [[Spermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]]&nbsp; [[AP-7 (drug)|AP7]]&nbsp; [[CGP-37849]]&nbsp; [[CGP-39551]]&nbsp; [[CGP-39653]]&nbsp; [[CGP-40116]]&nbsp; [[CGS-19755]]&nbsp; [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]]&nbsp; [[LY-233,053]]&nbsp; [[LY-235,959]]&nbsp; [[LY-274,614]]&nbsp; [[MDL-100,453]]&nbsp; [[Midafotel|Midafotel (d-CPPene)]]&nbsp; [[NPC-12,626]]&nbsp; [[NPC-17,742]]&nbsp; [[PBPD]]&nbsp; [[PEAQX]]&nbsp; [[Perzinfotel]]&nbsp; [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]]&nbsp; [[SDZ-220581]]&nbsp; [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]]&nbsp; [[Caroverine]]&nbsp; [[Dexanabinol]]&nbsp; [[FPL-12495]]&nbsp; [[FR-115,427]]&nbsp; [[Hodgkinsine]]&nbsp; [[Magnesium]]&nbsp; [[MDL-27,266]]&nbsp; [[NPS-1506]]&nbsp; [[Psychotridine]]&nbsp; [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]]&nbsp; [[3-MeO-PCP]]&nbsp; [[8a-Phenyldecahydroquinoline|8A-PDHQ]]&nbsp; [[Amantadine]]&nbsp; [[Aptiganel]]&nbsp; [[ARL-12,495]]&nbsp; [[ARL-15,896-AR]]&nbsp; [[ARL-16,247]]&nbsp; [[Budipine]]&nbsp; [[Delucemine]]&nbsp; [[Dexoxadrol]]&nbsp; [[Dextrallorphan]]&nbsp; [[Dieticyclidine]]&nbsp; [[Dizocilpine]]&nbsp; [[Endopsychosin]]&nbsp; [[Esketamine]]&nbsp; [[Etoxadrol]]&nbsp; [[Eticyclidine]]&nbsp; [[Gacyclidine]]&nbsp; [[Ibogaine]]&nbsp; [[Indantadol]]&nbsp; [[Ketamine]]&nbsp; [[Ketobemidone]]&nbsp; [[Loperamide]]&nbsp; [[Memantine]]&nbsp; [[Meperidine|Meperidine (Pethidine)]]&nbsp; [[Methadone]]&nbsp; [[Methorphan]] ([[Dextromethorphan]], [[Levomethorphan]])&nbsp; [[Methoxetamine]]&nbsp; [[Milnacipran]]&nbsp; [[Morphanol]] ([[Dextrorphan]], [[Levorphanol]])&nbsp; [[NEFA (drug)|NEFA]]&nbsp; [[Neramexane]]&nbsp; [[Nitrous oxide]]&nbsp; [[Noribogaine]]&nbsp; [[Orphenadrine]]&nbsp; [[PCPr]]&nbsp; [[Phencyclamine]]&nbsp; [[Phencyclidine]]&nbsp; [[Propoxyphene]]&nbsp; [[Remacemide]]&nbsp; [[Rhynchophylline]]&nbsp; [[Riluzole]]&nbsp; [[Rimantadine]]&nbsp; [[Rolicyclidine]]&nbsp; [[Sabeluzole]]&nbsp; [[Tenocyclidine]]&nbsp; [[Tiletamine]]&nbsp; [[Tramadol]]&nbsp; [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]]&nbsp; [[ACEA-1328]]&nbsp; [[1-Aminocyclopropanecarboxylic acid|ACPC]]&nbsp; [[Carisoprodol]]&nbsp; [[CGP-39653]]&nbsp; [[7-Chlorokynurenate|CKA]]&nbsp; [[DCKA]]&nbsp; [[Felbamate]]&nbsp; [[Gavestinel]]&nbsp; [[GV-196,771]]&nbsp; [[Kynurenic acid]]&nbsp; [[L-689,560]]&nbsp; [[L-701,324]]&nbsp; [[Lacosamide]]&nbsp; [[Licostinel]]&nbsp; [[LU-73,068]]&nbsp; [[MDL-105,519]]&nbsp; [[Meprobamate]]&nbsp; [[MRZ 2/576]]&nbsp; [[PNQX]]&nbsp; [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]]&nbsp; [[CO-101,244|CO-101,244 (PD-174,494)]]&nbsp; [[CP-101,606]]&nbsp; [[Eliprodil]]&nbsp; [[Haloperidol]]&nbsp; [[Ifenprodil]]&nbsp; [[Isoxsuprine]]&nbsp; [[Nylidrin]]&nbsp; [[Ro8-4304]]&nbsp; [[Ro25-6981]]&nbsp; [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]]&nbsp; [[Co 101676]]&nbsp; [[1,3-Diaminopropane|Diaminopropane]]&nbsp; [[Diethylenetriamine]]&nbsp; [[Huperzine A]]&nbsp; [[Putrescine]]&nbsp; [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]]&nbsp; [[Diethyl ether]]&nbsp; [[Enflurane]]&nbsp; [[Ethanol|Ethanol (Alcohol)]]&nbsp; [[Halothane]]&nbsp; [[Isoflurane]]&nbsp; [[Methoxyflurane]]&nbsp; [[Toluene]]&nbsp; [[1,1,1-Trichloroethane|Trichloroethane]]&nbsp; [[2,2,2-Trichloroethanol|Trichloroethanol]]&nbsp; [[Trichloroethylene]]&nbsp; [[Xylene]]
  
 
     | group3 = [[Kainate receptor|Kainate]]
 
     | group3 = [[Kainate receptor|Kainate]]
     | list3  = '''Agonists:''' [[5-Iodowillardiine]]&#160;&#8226;  [[ATPA]]&#160;&#8226;  [[Domoic acid]]&#160;&#8226;  [[Kainic acid]]&#160;&#8226;  [[LY-339,434]]&#160;&#8226;  [[SYM-2081]]<br/>'''Antagonists:''' [[CNQX]]&#160;&#8226;  [[DNQX]]&#160;&#8226;  [[LY-382,884]]&#160;&#8226;  [[NBQX]]&#160;&#8226;  [[NS102]]&#160;&#8226;  [[Tezampanel]]&#160;&#8226;  [[Topiramate]]&#160;&#8226;  [[UBP-302]]; ''Negative allosteric modulators:'' [[NS-3763]]
+
     | list3  = '''Agonists:''' [[5-Iodowillardiine]]&nbsp; [[ATPA]]&nbsp; [[Domoic acid]]&nbsp; [[Kainic acid]]&nbsp; [[LY-339,434]]&nbsp; [[SYM-2081]]<br/>'''Antagonists:''' [[CNQX]]&nbsp; [[DNQX]]&nbsp; [[LY-382,884]]&nbsp; [[NBQX]]&nbsp; [[NS102]]&nbsp; [[Tezampanel]]&nbsp; [[Topiramate]]&nbsp; [[UBP-302]]; ''Negative allosteric modulators:'' [[NS-3763]]
  
 
     }}
 
     }}
Line 25: Line 25:
  
 
     | group1 = [[Metabotropic_glutamate_receptor#Group_I|Group I]]
 
     | group1 = [[Metabotropic_glutamate_receptor#Group_I|Group I]]
     | list1  = '''Agonists:''' ''Unselective:'' [[ACPD]]&#160;&#8226;  [[Dihydroxyphenylglycine|DHPG]]&#160;&#8226;  [[Quisqualic acid]]; ''mGlu1-selective:'' [[Ro01-6128]]&#160;&#8226;  [[Ro67-4853]]&#160;&#8226;  [[Ro67-7476]]&#160;&#8226;  [[VU-71]]; ''mGlu5-selective:'' [[ADX-47273]]&#160;&#8226;  [[CDPPB]]&#160;&#8226;  [[CHPG]]&#160;&#8226;  [[1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine|DFB]]&#160;&#8226;  [[VU-1545]]<br/>'''Antagonists:''' ''Unselective:'' [[MCPG]]&#160;&#8226;  [[NPS-2390]]; ''mGlu1-selective:'' [[BAY 36-7620]]&#160;&#8226;  [[CPCCOEt]]&#160;&#8226;  [[LY-367,385]]&#160;&#8226;  [[LY-456,236]]; ''mGlu5-selective:'' [[DMeOB]]&#160;&#8226;  [[Fenobam]]&#160;&#8226;  [[LY-344,545]]&#160;&#8226;  [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]]&#160;&#8226;  [[MTEP]]&#160;&#8226;  [[SIB-1757]]&#160;&#8226;  [[SIB-1893]]  
+
     | list1  = '''Agonists:''' ''Unselective:'' [[ACPD]]&nbsp; [[Dihydroxyphenylglycine|DHPG]]&nbsp; [[Quisqualic acid]]; ''mGlu1-selective:'' [[Ro01-6128]]&nbsp; [[Ro67-4853]]&nbsp; [[Ro67-7476]]&nbsp; [[VU-71]]; ''mGlu5-selective:'' [[ADX-47273]]&nbsp; [[CDPPB]]&nbsp; [[CHPG]]&nbsp; [[1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine|DFB]]&nbsp; [[VU-1545]]<br/>'''Antagonists:''' ''Unselective:'' [[MCPG]]&nbsp; [[NPS-2390]]; ''mGlu1-selective:'' [[BAY 36-7620]]&nbsp; [[CPCCOEt]]&nbsp; [[LY-367,385]]&nbsp; [[LY-456,236]]; ''mGlu5-selective:'' [[DMeOB]]&nbsp; [[Fenobam]]&nbsp; [[LY-344,545]]&nbsp; [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]]&nbsp; [[MTEP]]&nbsp; [[SIB-1757]]&nbsp; [[SIB-1893]]  
  
 
     | group2 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group II]]
 
     | group2 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group II]]
     | list2  = '''Agonists:''' ''Unselective:'' [[CBiPES]]&#160;&#8226;  [[DCG-IV]]&#160;&#8226;  [[Eglumegad]]&#160;&#8226;  [[LY-379,268]]&#160;&#8226;  [[LY-404,039]]&#160;&#8226;  [[LY-487,379]]&#160;&#8226;  [[MGS-0028]]; ''mGlu2-selective:'' [[Biphenylindanone A|BINA]]&#160;&#8226;  [[LY-566,332]]<br/>'''Antagonists:''' ''Unselective:'' [[APICA (drug)|APICA]]&#160;&#8226;  [[EGLU]]&#160;&#8226;  [[HYDIA]]&#160;&#8226;  [[LY-307,452]]&#160;&#8226;  [[LY-341,495]]&#160;&#8226;  [[MCPG]]&#160;&#8226;  [[MGS-0039]]: ''mGlu2-selective:'' [[PCCG-4]]; ''mGlu3-selective:'' [[CECXG]]
+
     | list2  = '''Agonists:''' ''Unselective:'' [[CBiPES]]&nbsp; [[DCG-IV]]&nbsp; [[Eglumegad]]&nbsp; [[LY-379,268]]&nbsp; [[LY-404,039]]&nbsp; [[LY-487,379]]&nbsp; [[MGS-0028]]; ''mGlu2-selective:'' [[Biphenylindanone A|BINA]]&nbsp; [[LY-566,332]]<br/>'''Antagonists:''' ''Unselective:'' [[APICA (drug)|APICA]]&nbsp; [[EGLU]]&nbsp; [[HYDIA]]&nbsp; [[LY-307,452]]&nbsp; [[LY-341,495]]&nbsp; [[MCPG]]&nbsp; [[MGS-0039]]: ''mGlu2-selective:'' [[PCCG-4]]; ''mGlu3-selective:'' [[CECXG]]
  
 
     | group3 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group III]]
 
     | group3 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group III]]
     | list3  = '''Agonists:''' ''Unselective:'' [[L-AP4]]; ''mGlu4-selective:'' [[PHCCC]]&#160;&#8226;  [[VU-001,171]]&#160;&#8226;  [[VU-0155,041]]; ''mGlu7-selective:'' [[AMN082]]; ''mGlu8-selective:'' [[DCPG]]<br/>'''Antagonists:''' ''Unselective:'' [[CPPG]]&#160;&#8226;  [[MAP4 (drug)|MAP4]]&#160;&#8226;  [[MSOP (drug)|MSOP]]&#160;&#8226;  [[MPPG]]&#160;&#8226;  [[MTPG]]&#160;&#8226;  [[UBP-1112]]; ''mGlu7-selective:'' [[MMPIP]]
+
     | list3  = '''Agonists:''' ''Unselective:'' [[L-AP4]]; ''mGlu4-selective:'' [[PHCCC]]&nbsp; [[VU-001,171]]&nbsp; [[VU-0155,041]]; ''mGlu7-selective:'' [[AMN082]]; ''mGlu8-selective:'' [[DCPG]]<br/>'''Antagonists:''' ''Unselective:'' [[CPPG]]&nbsp; [[MAP4 (drug)|MAP4]]&nbsp; [[MSOP (drug)|MSOP]]&nbsp; [[MPPG]]&nbsp; [[MTPG]]&nbsp; [[UBP-1112]]; ''mGlu7-selective:'' [[MMPIP]]
  
 
     }}
 
     }}
  
   | group3 = [[Glutamate transporter|Transporter]]<br>[[Reuptake inhibitor|inhibitor]]s
+
   | group3 = [[Glutamate transporter|Transporter]]<br />[[Reuptake inhibitor|inhibitor]]s
 
   |  list3 = {{Navbox subgroup
 
   |  list3 = {{Navbox subgroup
 
   | groupstyle = background: LightYellow
 
   | groupstyle = background: LightYellow
  
 
     | group1 = [[Glutamate transporter|EAAT]]s
 
     | group1 = [[Glutamate transporter|EAAT]]s
     |  list1 = [[Dihydrokainic acid|DHKA]]&#160;&#8226;  [[L-trans-Pyrrolidine-2,4-dicarboxylic acid|PDC]]&#160;&#8226;  [[WAY-213,613]]
+
     |  list1 = [[Dihydrokainic acid|DHKA]]&nbsp; [[L-trans-Pyrrolidine-2,4-dicarboxylic acid|PDC]]&nbsp; [[WAY-213,613]]
  
 
     | group2 = [[Vesicular glutamate transporters|vGluTs]]
 
     | group2 = [[Vesicular glutamate transporters|vGluTs]]
     |  list2 = [[7-Chlorokynurenic acid|7-CKA]]&#160;&#8226;  [[Evans blue]]
+
     |  list2 = [[7-Chlorokynurenic acid|7-CKA]]&nbsp; [[Evans blue]]
  
 
   }}
 
   }}

Revision as of 09:17, 3 January 2011